Ontario Superior Court dismisses Apotex’s Statutes of Monopolies and Trademarks Act claims regarding olanzapine

Published date01 April 2021
Subject MatterPatents,Summary Judgment,Dismissals,Patent Litigation,Pharmaceutical Patents,Canada,Intellectual Property Protection,The Patent Act,Trademarks Act,PMNOC Regulations,Statute of Monopolies
AuthorBrandon Heard
Law FirmSmart & Biggar

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT